News
Zacks.com on MSN14h
Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.
Zacks Investment Research on MSN4d
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
Bristol Myers is making waves after a period of pressure. The stock jumped 6.3% recently, outperforming its industry and the ...
David V. Elkins currently works at Tapestry, Inc., as Independent Director from 2024 and Bristol Myers Squibb Co., as Chief Financial Officer & Executive Vice President. Mr. Elkins also formerly ...
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback